1Tang L,Dai DL,Su M,et al.Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers.Clin Cancer Res,2006,12:3716-3722. 被引量：1
2Pyagay P,Heroult M,Wang Q,et al.Collagen triple helix repeat containing 1,a novel secreted protein in injured and diseased arteries,inhibits collagen expression and promotes cell migration.Circ Res,2005,96:261-268. 被引量：1
3LeClair R,Lindner V.The role of collagen triple helix repeat containing 1 in injured arteries,collagen expression,and transforming growth factor beta signaling.Trends Cardiovasc Med,2007,17:202-205. 被引量：1
4Durmus T,LeClair RJ,Park KS,et al.Expression analysis of the novel gene collagen triple helix repeat containing-1 (Cthrc1).Gene Expr Patterns,2006,6:935-940. 被引量：1
5LeClair RJ,Durmus T,Wang Q,et al.CTHRC1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation.Circ Res,2007,100:826-833. 被引量：1
6Dvorak HF.Tumors:wounds that do not heal.Similarities between tumor stroma generation and wound healing.N Engl J Med,1986,315:1650-1659. 被引量：1
7Beachy PA,Karhadkar SS,Berman DM.Tissue repair and stem cell renewal in carcinogenesis.Nature,2004,432:324-331. 被引量：1
8Coussens LM,Werb Z.Inflammation and cancer.Nature,2002,420:860-867. 被引量：1
9Kimura H,Kwan KM,Zhang Z,et al.Cthrc1 is a positive regulator of osteoblastic bone formation.PloS ONE,2008,3:e3174. 被引量：1
10Allinen M,Beroukhim R,Cai L,et al.Molecular characterization of the tumor microenvironment in breast cancer.Cancer Cell,2004,6:17-32. 被引量：1
5Kwong KF.Molecular biology of esophageal cancer in the genomics era.Surg Clin North Am,2005,85:539-553. 被引量：1
6Smeds J,Miller LD,Bjohle J,et al.Gene profile and response to treatment.Ann Oncol,2005,16 Suppl 2:ii195-ii202. 被引量：1
7Hirao M,Onai N,Hiroishi K,et al.CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells,critical role in migration from the tumor site to draining lymph nodes.Cancer Res,2000,60 2209-2217. 被引量：1
8Gerard C,Rollins BJ.Chemokines and disease.Nat Immunol,2001,2:108-115. 被引量：1
9Teraishi F,Kagawa S,Watanabe T,et al.ZD1839 (Gefitinib,'Iressa'),an epidermal growth factor receptortyrosine kinase inhibitor,enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma.FEBS Lett,2005,579:4069-4075. 被引量：1
10Kerkela E,Saarialho-Kere U.Matrix metalloproteinascs in tumor progression:focus on basal and squamous cell skin cancer.Exp Dermatol,2003,12:109-125. 被引量：1
